Quick Overview.
RAD-140, commonly known as Testolone, is a highly potent Selective Androgen Receptor Modulator (SARM) originally developed by Radius Health Inc. It was designed as a potential treatment for muscle wasting and, notably, as a targeted therapy for certain types of breast cancer. In the bodybuilding and fitness communities, it is widely considered the strongest SARM available for building "dry" muscle mass and increasing sheer strength.[1][2]
If LGD-4033 is the "wet mass" builder, RAD-140 is the "dry strength" builder. It binds to the androgen receptor with an affinity that rivals or exceeds that of testosterone itself. Because of its extreme potency, it produces rapid increases in strength and muscle density, but it also comes with severe testosterone suppression, increased aggression, and significant liver stress.[3]
- Primary Use Case: Rapid strength gains, dry muscle mass accumulation, and body recomposition.
- Mechanism: Highly selective, high-affinity agonism of the androgen receptor in skeletal muscle and bone.[4]
- Who it is for: Advanced users looking for steroid-like strength gains without the water retention of LGD-4033.
- Who it is NOT for: Beginners, women (due to high virilization risk), or anyone prone to hair loss or anger issues.
Turn this protocol into your actual schedule.
Log every dose, every side-effect, and every PR on one timeline.
The Protocol & Usage Guide.
confidence_tier: well-established
RAD-140 is orally bioavailable. While its half-life was originally thought to be 24 hours, more recent pharmacokinetic data suggests it may have a half-life closer to 60 hours. Despite this, it is still typically dosed once per day.[5]
Standard Dosing Schedule
| Phase | Dose | Frequency | Timing |
|---|---|---|---|
| Beginner / Recomp | 5 mg to 10 mg | Daily | Morning, with or without food |
| Standard Bulking/Strength | 10 mg to 15 mg | Daily | Morning, with or without food |
| Advanced Strength | 20 mg | Daily | Morning, with or without food |
| Women | NOT RECOMMENDED | N/A | High risk of virilization. Use Ostarine instead. |
Cycle Length & Discontinuation Protocol
- Cycle Length: 6 to 8 weeks. Do not exceed 8 weeks. The side effects (suppression, liver stress, hair shedding) compound rapidly after week 6.
- Discontinuation (PCT): RAD-140 is severely suppressive. A full Post Cycle Therapy (PCT) using Enclomiphene (12.5mg daily for 4 weeks) or Nolvadex (20mg daily for 4 weeks) is absolutely mandatory to restore natural testosterone production.[6]
Nutritional Support & Recommended Supplements.
confidence_tier: well-established
| Supplement | Rationale | Recommended Dose |
|---|---|---|
| NAC or TUDCA | RAD-140 is notoriously harsh on the liver compared to other SARMs. Liver support is mandatory. | NAC: 1200mg daily. TUDCA: 500mg daily. |
| Citrus Bergamot | RAD-140 will severely crash HDL (good cholesterol) and spike LDL. | 500-1000mg daily. |
| Omega-3 Fish Oil | Additional cardiovascular and lipid support. | 3-4g daily. |
Safety, Interactions & Side Effect Management.
confidence_tier: well-established
Side Effect Profile
| Side Effect | Severity | Frequency | Management |
|---|---|---|---|
| Testosterone Suppression | Severe | Universal | Mandatory PCT. Many users run a "SARM+SERM" cycle to combat this mid-cycle. |
| Hair Shedding | Moderate/Severe | Common | RAD-140 is notorious for accelerating male pattern baldness in prone individuals. |
| Increased Aggression | Moderate | Common | Often referred to as "RAD-somnia" or "RAD-rage." Monitor mood and sleep hygiene. |
| Liver Enzyme Elevation | Severe | Common | Use NAC or TUDCA. Avoid alcohol completely. |
Contraindications
- Absolute: Individuals with pre-existing liver disease or severe cardiovascular issues.
- Absolute: Teenagers whose endocrine systems are still developing.
- Relative: Individuals prone to male pattern baldness or anger management issues.
Drug Interactions
- Alcohol: Severe. Combining RAD-140 with alcohol places immense stress on the liver and significantly increases the risk of drug-induced liver injury (DILI).
- Accutane / Hepatotoxic Drugs: Severe. Do not stack with other liver-toxic medications.
Common Stacks & Combinations.
confidence_tier: community
| Stack | Goal | Rationale |
|---|---|---|
| RAD-140 + MK-677 | Dry Mass & Recovery | RAD-140 builds the dense muscle tissue and strength, while MK-677 (Ibutamoren) aids in sleep, recovery, and joint health. |
| RAD-140 + Enclomiphene | SARM+SERM Cycle | Taking Enclomiphene (6.25mg - 12.5mg) during the RAD-140 cycle prevents the severe lethargy associated with testosterone suppression. |
Body Composition & Training Guide.
confidence_tier: community
- The Strength King: RAD-140 is famous for producing rapid, almost steroid-like increases in strength. Users frequently report adding 20-40 lbs to their compound lifts within a 6-week cycle.
- The "Dry" Look: Unlike LGD-4033, which causes water retention, RAD-140 pulls water out of the subcutaneous layer, giving the muscles a hard, dense, and vascular appearance.
- CNS Fatigue: Because RAD-140 allows users to lift significantly heavier weights very quickly, the central nervous system (CNS) and tendons often struggle to keep up. Users must be careful not to tear a muscle or tendon due to rapid strength increases.
Storage, Handling & Accessibility.
confidence_tier: well-established
- Storage: Store liquid solutions or capsules at room temperature in a cool, dark place.
- WADA Status: Banned in competitive sports under section S1.2 (Other Anabolic Agents). It has a long detection window.
- Cost & Accessibility: Widely available from research chemical vendors. Typically costs $50-$80 for a 30mL bottle (usually dosed at 10mg/mL).
Bloodwork Monitoring Guide.
confidence_tier: well-established
| Biomarker | When to Test | Why it Matters |
|---|---|---|
| Total & Free Testosterone | Baseline, Post-Cycle | RAD-140 will crush your natural testosterone. You must verify recovery post-PCT. |
| AST / ALT (Liver) | Baseline, Mid-Cycle | RAD-140 is highly hepatotoxic at bodybuilding doses. |
| Lipid Panel (HDL/LDL) | Baseline, Post-Cycle | RAD-140 reliably crashes HDL. You must ensure it recovers post-cycle. |
Comparison to Similar Compounds.
confidence_tier: well-established
| Feature | RAD-140 (Testolone) | LGD-4033 (Ligandrol) | Ostarine (MK-2866) |
|---|---|---|---|
| Primary Goal | Strength / Dry Mass | Bulking / Wet Mass | Cutting / Recomp |
| Potency | Very Strong | Strong | Mild |
| Suppression | Severe | Severe | Mild to Moderate |
| Water Retention | None (Drying) | High | None |
Deep Dive (For Advanced Researchers).
confidence_tier: well-established
Mechanism of Action
RAD-140 is a non-steroidal selective androgen receptor modulator. It binds to the androgen receptor (AR) with an extremely high affinity (Ki = 7 nM), which is roughly equivalent to the binding affinity of dihydrotestosterone (DHT). It acts as a full agonist in skeletal muscle and bone, but acts as a partial agonist (or even an antagonist) in the prostate and seminal vesicles.[7]
Clinical Trial Summary
Unlike Ostarine and LGD-4033, which were primarily studied for muscle wasting, RAD-140's clinical development pivoted heavily toward oncology.
- Breast Cancer Efficacy: In preclinical models and a Phase I human trial, RAD-140 was shown to be highly effective at inhibiting the growth of Androgen Receptor-positive (AR+) / Estrogen Receptor-positive (ER+) breast cancer. It does this by binding to the AR and repressing the ESR1 gene, effectively starving the cancer cells of estrogenic signaling.[8][9]
- Neuroprotection: In rat models, RAD-140 demonstrated significant neuroprotective effects. It was shown to protect hippocampal neurons against apoptosis induced by amyloid-beta (the protein associated with Alzheimer's disease) as effectively as testosterone, but without the peripheral androgenic side effects.[10]
Pharmacokinetics & Half-Life
Early literature cited a 24-hour half-life for RAD-140. However, a 2022 pharmacokinetic study analyzing micro-dosed RAD-140 in humans found that the terminal elimination half-life is actually closer to 60 hours. This means the drug accumulates significantly in the body over a cycle, which explains why side effects often become severe around week 4 or 5.[11]
Hepatotoxicity
RAD-140 is increasingly recognized in medical literature as a significant cause of drug-induced liver injury (DILI). Multiple case reports detail young men presenting with severe jaundice, pruritus (itching), and highly elevated liver enzymes (AST/ALT) after using RAD-140 for 4 to 8 weeks. The liver injury is typically characterized as cholestatic (impaired bile flow) and can take months to fully resolve.[12][13]
Frequently Asked Questions (FAQ).
confidence_tier: community
Q: Will RAD-140 make my hair fall out? A: It is highly possible. RAD-140 is notorious in the community for causing hair shedding. If you are genetically predisposed to male pattern baldness, RAD-140 will likely accelerate it.
Q: Do I really need a PCT for RAD-140? A: Absolutely. RAD-140 is severely suppressive. At bodybuilding doses (10-20mg), your natural testosterone production will be shut down. A SERM PCT is mandatory.
Q: Why am I so angry on RAD-140? A: RAD-140 is known to cause increased aggression, irritability, and insomnia in some users. This is likely due to its extremely high binding affinity to androgen receptors in the brain, mimicking the psychological effects of high-dose androgens.
International Regulatory Status.
confidence_tier: well-established
| Agency | Status | Notes |
|---|---|---|
| US FDA | Investigational | Not approved for human consumption. Sold legally only as a "research chemical." |
| WADA | Banned | Prohibited at all times under S1.2. |
| UK MHRA | Unlicensed | Illegal to sell as a food supplement; legal to possess for research. |
| EU EMA | Unlicensed | Not approved for medical use. |
Decision Tree.
confidence_tier: community
[Goal: Maximum Strength and Dry Muscle Mass?]
|
+-- Are you prone to hair loss or anger issues?
|
+-- (Yes) -> Avoid RAD-140. Consider Ostarine or LGD-4033.
|
+-- (No) -> Are you willing to run a full PCT?
|
+-- (Yes) -> Take 10mg daily for 6-8 weeks.
Take Liver Support (NAC) daily.
Follow with 4 weeks of Enclomiphene (PCT).Schema.org Data.
{
"@context": "https://schema.org",
"@type": "MedicalEntity",
"name": "RAD-140",
"alternateName": ["Testolone"],
"description": "A highly potent, non-steroidal selective androgen receptor modulator (SARM) investigated for breast cancer and muscle wasting, widely used off-label for rapid increases in strength and dry muscle mass.",
"legalStatus": {
"@type": "DrugLegalStatus",
"description": "Investigational new drug. Not FDA approved. Banned by WADA."
}
}What we cited.
- Narayanan R, et al. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal. 2008;6:e010. doi:10.1621/nrs.06010
- Miller CP, et al. Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140. ACS Med Chem Lett. 2010;2(2):124-129. doi:10.1021/ml1002508
- Bhasin S, et al. Selective androgen receptor modulators (SARMs) as function promoting therapies. Curr Opin Clin Nutr Metab Care. 2009;12(3):232-240. doi:10.1097/MCO.0b013e32832a3d79
- Yin D, et al. Pharmacodynamics of selective androgen receptor modulators. J Pharmacol Exp Ther. 2003;304(3):1334-1340. doi:10.1124/jpet.102.040840
- Wagener F, et al. Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes. Metabolites. 2022;12(8):704. doi:10.3390/metabo12080704
- Coss CC, et al. Selective androgen receptor modulators for the treatment of late onset male hypogonadism. Asian J Androl. 2014;16(2):256-261. doi:10.4103/1008-682X.122338
- Miller CP, et al. Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140. ACS Med Chem Lett. 2010;2(2):124-129. doi:10.1021/ml1002508
- Yu Z, et al. Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor-Positive Breast Cancer Models with a Distinct Mechanism of Action. Clin Cancer Res. 2017;23(24):7608-7620. doi:10.1158/1078-0432.CCR-17-0670
- Hamilton E, et al. A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/AR+/HER2- Advanced Breast Cancer. Clin Breast Cancer. 2022;22(1):53-61. doi:10.1016/j.clbc.2021.08.003
- Jayaraman A, et al. Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats. Endocrinology. 2014;155(4):1398-1406. doi:10.1210/en.2013-1725
- Wagener F, et al. Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes. Metabolites. 2022;12(8):704. doi:10.3390/metabo12080704
- Leung K, et al. RAD-140 Drug-Induced Liver Injury. Ochsner J. 2022;22(4):361-365. doi:10.31486/toj.22.0004
- Perananthan V, et al. Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building. Aust Prescr. 2024;47(1):16-18. doi:10.18773/austprescr.2024.003